<DOC>
	<DOCNO>NCT01941888</DOCNO>
	<brief_summary>Many study address safety effectiveness non-anesthesiologist propofol sedation ( NAPS ) GI endoscopy . Target Controlled Infusion ( TCI ) sophisticate tool provide optimal sedation regimen avoid oversedation . This randomized double blind control study compare standard moderate sedation level sedation ( group S ) upper endoscopy ( EGD ) colonoscopy ( CS ) versus propofol NAPS ( group P ) .</brief_summary>
	<brief_title>Propofol TCI Administered Gastroenterologists During Endoscopy : Randomized Double Blind Controlled Study</brief_title>
	<detailed_description>70 CS 70 EGD ASA I-II patient study . In group S ( n=70 ) administer fentanyl ( 1μg/kg ) + midazolam ( 0.04-0.03 mg/kg ) CS midazolam ( 0.04-0.03 mg/kg ) EGDS group P ( n=70 ) fentanyl 1µg/Kg + propofol TCI 1.2-1.6 μg/ml CS propofol TCI 1.2-1.6 μg/ml EGD . Vital parameters Observer 's Assessment Alertness Sedation Scale ( OAA/S ) monitor throughout study . Endoscopist 's patient 's satisfaction measure procedure 24-72 h later visual analog scale ( VAS ) .</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>age &gt; 18 yr ASA ( American Society Anesthesiologists risk class IIIIV ) III patient undergo gastroscopy colonoscopy significant systemic disease ( American Society Anesthesiologists risk class IIIIV ) history allergic reaction study drug chronic use opioid analgesic psychiatric disorder pregnancy difficult airway ( Mallampati score &gt; 2 ) age &lt; 18 yr</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>